Intaraprasong Pongphob, Sobhonslidsuk Abhasnee, Tongprasert Sasinee
Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
J Med Assoc Thai. 2010 Nov;93(11):1340-3.
Liver transplantation is an accepted management for end stage liver disease, early-stage hepatocellular carcinoma, and acute liver failure. The number of patients with end stage liver disease is growing rapidly. Living Donor Liver Transplantation (LDLT) has become an important alternative to cadaveric organ transplant for patients with end stage liver disease. On average, about one in three potential donors eventually donate part of their liver The overall reported donor mortality was 0.2% and median morbidity of l6%. Understanding donor outcomes is important as it enables the transplant team to fully inform the potential donor In addition, this information will help the transplant team improve their post operative management and plan for long-term follow-up after liver donation.
肝移植是终末期肝病、早期肝细胞癌和急性肝衰竭公认的治疗方法。终末期肝病患者的数量正在迅速增长。活体肝移植（LDLT）已成为终末期肝病患者尸体器官移植的重要替代方法。平均而言，大约三分之一的潜在供体最终会捐献部分肝脏。报告的总体供体死亡率为0.2%，中位发病率为16%。了解供体的预后很重要，因为这能使移植团队充分告知潜在供体。此外，这些信息将有助于移植团队改善术后管理，并为肝捐赠后的长期随访制定计划。
